Early Modulation of Systemic Inflammatory Indices During Propranolol Therapy in Infantile Hemangiomas
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/4769813 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 18.06.2026. Verfasst von Hubert Arasiewicz und 2 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Propranolol is the first‐line systemic therapy for infantile hemangiomas (IHs). Beyond its vasoconstrictive and antiangiogenic effects, emerging evidence suggests immunomodulatory actions that may be reflected in systemic inflammatory indices derived from routine complete blood count (CBC) parameters.
Objectives
To evaluate short‐term changes in CBC‐derived inflammatory ratios—neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), lymphocyte‐to‐monocyte ratio (LMR), systemic immune–inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI)—in infants with IH treated with propranolol.
Methods
In this retrospective single‐center study, infants with IH received oral propranolol 1–2 mg/kg/day. CBC was obtained before treatment initiation (T 0 ) and after about 1 month (T 1 ). Ratios were calculated from neutrophil, lymphocyte, monocyte, and platelet counts. Of 155 treated children, inflammatory indices were available for 123 at T 0 and 74 at T 1 ; 65–66 patients had paired measurements. The normality of variables’ distribution was evaluated with the Shapiro–Wilk test. The differences in mean values of inflammatory factors between two moments (T 0 and T 1 , respectively) were analyzed with the paired t ‐test or the Wilcoxon signed‐rank test.
Results
Baseline median (interquartile range [IQR]) values were as follows: NLR 0.26 (0.23), PLR 62.92 (32.21), LMR 8.75 (4.95), SIRI 0.18 (0.21), SII 102.58 (83.01), and AISI 72.50 (86.45). After 1 month of propranolol therapy, PLR decreased significantly ( p = 0.002), while LMR increased significantly ( p = 0.02). NLR, SII, SIRI, and AISI demonstrated mild, nonsignificant downward trends. No hematologic toxicity was observed.
Conclusions
Propranolol therapy in infants with IH is associated with early, selective modulation of systemic inflammatory balance, most prominently reflected by reduced PLR and increased LMR. These readily available CBC‐derived ratios may reflect early biological response to propranolol and may complement clinical assessment in selected cases. However, these findings should be interpreted as exploratory and require prospective validation against standardized clinical outcomes.
Zitieren
APA
Arasiewicz, H., Dec, M., & Kowalska, M. (2026). Early Modulation of Systemic Inflammatory Indices During Propranolol Therapy in Infantile Hemangiomas. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/4769813
Vancouver
Arasiewicz H, Dec M, Kowalska M. Early Modulation of Systemic Inflammatory Indices During Propranolol Therapy in Infantile Hemangiomas. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/4769813
BibTeX
@article{Arasiewicz2026,
author = {Arasiewicz, Hubert and Dec, Michal and Kowalska, Malgorzata},
title = {Early Modulation of Systemic Inflammatory Indices During Propranolol Therapy in Infantile Hemangiomas},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/4769813}
}
EUVIMED